This study demonstrates that multimerization of single-domain antibodies (VHHs) targeting MPXV M1R significantly enhances neutralizing activity. the approach offers a modular platform for engineering next-generation antivirals against orthopoxviruses.
- Daisuke Akazawa
- Masayuki Shimojima
- Koichi Watashi